Internet Explorer 8 Warnung Anscheinend verwenden Sie einen älteren Internet Explorer. Leider unterstützen wir, genau wie Microsoft, diesen Browser nicht mehr. Sie werden also Fehlermeldungen und ein inkonsistentes Design erleben.
Bitte haben Sie Verständnis und entschuldigen Sie die Unannehmlichkeiten.
Logo HTGF

News

Hematris – Specialist in blood clotting – attracts new investors

Aurelia Private Equity and KfW, the bank for medium-sized companies, are investing 2.0 million EUR in Hematris Wound Care. An investment for getting Hematrix® onto the market.

Hematris Wound Care GmbH has developed a unique wound patch, the “active“ patch Hematrix®. This patch stops the most severe, even arterial injury-related bleeding and external bleeding caused by surgical intervention in just a few minutes. The biodegradable patch is coated with blood-clotting components.

Hematrix® is being launched on the market by the 2.0 million EUR investment by Aurelia Private Equity GmbH, Frankfurt and die KfW Mittelstandsbank.

Dr. Stefan Bertsch, founder of Hematris is excited about the investment: There is no competition for “Hematrix® anywhere in the world. Working together with our new investors, we have the potential to position ourselves in a lucrative and growing market environment and develop new applications in the field of external blood clotting“. According to Georg Langer, Head of Sales at Hematrix, Hematrix® will be marketed in both medial/clinical and emergency and rescue environments.

Wolfgang Posselt, CEO of Aurelia Private Equity sees an enormous potential for this Hematris product and the real appeal of the investment. Jens Unger of the KfW Banking Group shares this opinion.

Backed by the seed financing in Hematris Wound Care by High-Tech Gründerfonds together with Berliner Peppermint Holding GmbH, the preclinical prototype of this wound patch has been developed into a marketable product. Following clinical studies on patients achieving impressive results in stopping arterial bleeding, Hematris satisfied the CE Certification requirements needed to launch the product.

Contact:
Hematris Wound Care GmbH
Dr. Dr. Stefan Bertsch
Lena-Christ-Str. 31 b
85521 Ottobrunn-Munich
Tel: +49 (0) 89 6008761 0 (11)
Fax: +49 (0) 89 6008761 24
bertsch@hematris.de
www.hematris.de

About AURELIA PRIVAT EQUITY GmbH:
AURELIA PRIVATE EQUITY invests in innovative technology companies in Germany. Investments are made in companies involved in IT, Life Sciences and Industry Innovations that are led by outstanding management and products with a clear competitive edge. For further information, visit www.aurelia-pe.de.

Contact:
AURELIA PRIVATE EQUITY GmbH
Kurhessenstr. 1-3
60431 Frankfurt
Tel: +49 (0) 69 80 90 0
Fax: +49 (0) 69 80 90 109
info@aurelia-pe.de
www.aurelia-pe.de

About KfW-Bankengruppe:
Die KfW-Bankengruppe unterstützt Gründer und mittelständische Unternehmer durch klassische Fremdkapitalfinanzierungen aber auch durch zahlreiche andere innovative Produkte zur Verbesserung der Eigenkapitalausstattung, wie zum Beispiel dem ERP-Startfonds. Weitere Informationen unter www.kfw.de.

Contact :
KfW Bankengruppe
Wolfram Schweickhardt
Pressestelle,
Palmengartenstr. 5-9
60325 Frankfurt
Tel.: +49 (0) 69-7431 1778
Fax +49 (0) 69-7431 3266
www.kfw.de